← Leaderboards
Suzanne A Fuqua
Baylor College Of Medicine
$14,426,929
Attributed
$14,932,009
Total exposure
15
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,932,009 · 15
By mechanism
R01$8,209,129 · 2
T32$3,079,455 · 2
P01$1,465,819 · 1
P50$1,388,803 · 4
P30$788,803 · 6
Top collaborators
- Matthew J Ellis3 shared
- Mothaffar Fahed Rimawi2 shared
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Yi Li$11,171,360
- Shixia Huang$1,196,679
- Diana S-L. Chow$1,578,070
Others in their field
Top investigators on “Estrogen Receptors”
- Susan E. Hankinson · University Of Massachusetts Amherst$30,736,590
- David Heimbrook · Leidos Biomedical Research, Inc.$29,594,272
- Bert W O'Malley · Baylor College Of Medicine$28,464,172
- Norman Wolmark · Nsabp Foundation, Inc.$27,593,122
- Howard N Hodis · University Of Southern California$24,496,214
- Donald P McDonnell · Duke University$19,513,822
Research focus
Estrogen ReceptorsMalignant Breast NeoplasmHormone TherapyTumorSignal TransductionGrowthResistanceEstrogensGenesPathway InteractionsMutantMutationMammary NeoplasmsResearch PersonnelCellsAffectPhenotypeNeoplasm MetastasisMalignant NeoplasmsEngineeringWomanAromatase InhibitorsRecurrenceResponse
Grant awards (79)
Replication Stress and DNA Damage Response Drives ESR1 Mutant Metastasis$342,000
R01 · FY2025 · CA · contact PI
Cancer Research Training and Education Coordination$200,350
P30 · FY2025 · CA · contact PI
Chromatin Biology$52,683
P30 · FY2025 · CA · contact PI
Replication Stress and DNA Damage Response Drives ESR1 Mutant Metastasis$324,901
R01 · FY2024 · CA · contact PI
Cancer Research Career Enhancement and Related Activities$86,825
P30 · FY2024 · CA · contact PI
Career Enhancement Program (CEP)$70,766
P50 · FY2024 · CA · contact PI
Nuclear Receptor, Transcription and Chromatin Biology Program$32,567
P30 · FY2024 · CA · contact PI
Replication Stress and DNA Damage Response Drives ESR1 Mutant Metastasis$342,000
R01 · FY2023 · CA · contact PI
Cancer Research Career Enhancement and Related Activities$86,825
P30 · FY2023 · CA · contact PI
Career Enhancement Program (CEP)$86,387
P50 · FY2023 · CA · contact PI
Nuclear Receptor, Transcription and Chromatin Biology Program$32,567
P30 · FY2023 · CA · contact PI
Replication Stress and DNA Damage Response Drives ESR1 Mutant Metastasis$342,000
R01 · FY2022 · CA · contact PI
Translational Breast Cancer Research Training Program$193,635
T32 · FY2022 · CA · contact PI
Cancer Research Career Enhancement and Related Activities$86,825
P30 · FY2022 · CA · contact PI
Career Enhancement Program (CEP)$73,214
P50 · FY2022 · CA · contact PI
Nuclear Receptor, Transcription and Chromatin Biology Program$32,567
P30 · FY2022 · CA · contact PI
MECHANISMS OF AR-ER COLLABORATION IN HORMONE RESISTANCE AND METASTASIS OF BREAST CANCER$362,569
R01 · FY2021 · CA · contact PI
Translational Breast Cancer Research Training Program$207,275
T32 · FY2021 · CA · contact PI
Cancer Research Career Enhancement and Related Activities$90,769
P30 · FY2021 · CA · contact PI
Career Enhancement Program (CEP)$73,201
P50 · FY2021 · CA · contact PI
MECHANISMS OF AR-ER COLLABORATION IN HORMONE RESISTANCE AND METASTASIS OF BREAST CANCER$362,569
R01 · FY2020 · CA · contact PI
Translational Breast Cancer Research Training Program$211,871
T32 · FY2020 · CA · contact PI
Career Enhancement Program (CEP)$88,244
P50 · FY2020 · CA · contact PI
Cancer Research Career Enhancement and Related Activities$86,825
P30 · FY2020 · CA · contact PI
MECHANISMS OF AR-ER COLLABORATION IN HORMONE RESISTANCE AND METASTASIS OF BREAST CANCER$351,691
R01 · FY2019 · CA · contact PI
Translational Breast Cancer Research Training Program$202,856
T32 · FY2019 · CA · contact PI
MECHANISMS OF AR-ER COLLABORATION IN HORMONE RESISTANCE AND METASTASIS OF BREAST CANCER$362,569
R01 · FY2018 · CA · contact PI
Integration of Predictive Biomarkers of Hormone Resistance in Breast Cancer$320,963
R01 · FY2018 · CA · contact PI
Translational Breast Cancer Research Training Program$194,523
T32 · FY2018 · CA · contact PI
MECHANISMS OF AR-ER COLLABORATION IN HORMONE RESISTANCE AND METASTASIS OF BREAST CANCER$362,569
R01 · FY2017 · CA · contact PI
Integration of Predictive Biomarkers of Hormone Resistance in Breast Cancer$320,963
R01 · FY2017 · CA · contact PI
Integration of Predictive Biomarkers of Hormone Resistance in Breast Cancer$320,963
R01 · FY2016 · CA · contact PI
Integration of Predictive Biomarkers of Hormone Resistance in Breast Cancer$320,963
R01 · FY2015 · CA · contact PI
Integration of Predictive Biomarkers of Hormone Resistance in Breast Cancer$319,275
R01 · FY2014 · CA · contact PI
A Hypersensitive ER alpha Mutant in Breast Cancer Hormone Resistance$291,192
R01 · FY2012 · CA · contact PI
Translational Breast Cancer Research Training Program$236,892
T32 · FY2012 · CA · contact PI
Role of Androgen Receptor in Breast Cancer Progression$222,397
P50 · FY2012 · CA · contact PI
A Hypersensitive ER alpha Mutant in Breast Cancer Hormone Resistance$49,685
R01 · FY2012 · CA · contact PI
A Hypersensitive ER alpha Mutant in Breast Cancer Hormone Resistance$291,193
R01 · FY2011 · CA · contact PI
Role of Androgen Receptor in Breast Cancer Progression$224,968
P50 · FY2011 · CA · contact PI
Translational Breast Cancer Research Training Program$114,203
T32 · FY2011 · CA · contact PI
A Hypersensitive ER alpha Mutant in Breast Cancer Hormone Resistance$49,857
R01 · FY2011 · CA · contact PI
A Hypersensitive ER alpha Mutant in Breast Cancer Hormone Resistance$300,198
R01 · FY2010 · CA · contact PI
Role of Androgen Receptor in Breast Cancer Progression$238,094
P50 · FY2010 · CA · contact PI
Translational Breast Cancer Research Training Program$194,626
T32 · FY2010 · CA · contact PI
A Hypersensitive ER alpha Mutant in Breast Cancer Hormone Resistance$51,581
R01 · FY2010 · CA · contact PI
A Hypersensitive ER alpha Mutant in Breast Cancer Hormone Resistance$300,198
R01 · FY2009 · CA · contact PI
Translational Breast Cancer Research Training Program$263,406
T32 · FY2009 · CA · contact PI
Role of Androgen Receptor in Breast Cancer Progression$156,247
P50 · FY2009 · CA · contact PI
RNA Expression and CGH Profiles to Predict Long-Term Breast Progression$334,860
P01 · FY2008 · CA · contact PI
A Hypersensitive ER alpha Mutant in Breast Cancer Hormone Resistance$300,198
R01 · FY2008 · CA · contact PI
Translational Breast Cancer Research Training Program$270,534
T32 · FY2008 · CA · contact PI
Role of Androgen Receptor in Breast Cancer Progression$155,285
P50 · FY2008 · CA · contact PI
RNA Expression and CGH Profiles to Predict Long-Term Breast Progression$334,016
P01 · FY2007 · CA · contact PI
A Hypersensitive Estrogen Receptor a Mutant in Breast Cancer Progression$285,759
R01 · FY2007 · CA · contact PI
A Hypersensitive ERa Mutant in Breast Cancer Progression$294,294
R01 · FY2006 · CA · contact PI
RNA Expression/CGH Profiles to Predict Breast Cancer Gro$210,963
P01 · FY2006 · CA · contact PI
Translational Breast Cancer Research Training Program$198,937
T32 · FY2006 · CA · contact PI
A Hypersensitive ERa Mutant in Breast Cancer Progression$301,376
R01 · FY2005 · CA
RNA Expression/CGH Profiles to Predict Breast Cancer Gro$205,119
P01 · FY2005 · CA
Translational Breast Cancer Research Training Program$173,824
T32 · FY2005 · CA
A Hypersensitive ERa Mutant in Breast Cancer Progression$301,376
R01 · FY2004 · CA
Translational Breast Cancer Research Training Program$209,733
T32 · FY2004 · CA
RNA Expression/CGH Profiles to Predict Breast Cancer Gro$199,374
P01 · FY2004 · CA
A Hypersensitive ERa Mutant in Breast Cancer Progression$361,576
R01 · FY2003 · CA
Translational Breast Cancer Research Training Program$212,260
T32 · FY2003 · CA
Translational Breast Cancer Research Training Program$194,880
T32 · FY2002 · CA
HYPERSENSITIVE ESTROGEN RECEPTOR IN PREMALIGNANT BREAST$24,005
R01 · FY2002 · CA
HEAT SHOCK PROTEINS AND DRUG RESISTANCE$0
P50 · FY2002 · CA
HEAT SHOCK PROTEINS AND DRUG RESISTANCE$0
P50 · FY2002 · CA
HEAT SHOCK PROTEINS AND DRUG RESISTANCE$0
P50 · FY2002 · CA
MOLECULAR VARIANTS &OVEREXPRESSION OF ESTROGEN RECEPTORS IN BREAST CANCER$0
P01 · FY2002 · CA
MOLECULAR VARIANTS &OVEREXPRESSION OF ESTROGEN RECEPTORS IN BREAST CANCER$0
P01 · FY2001 · CA
HEAT SHOCK PROTEINS AND DRUG RESISTANCE$0
P50 · FY2001 · CA
HEAT SHOCK PROTEINS AND DRUG RESISTANCE$0
P50 · FY2001 · CA
HYPERSENSITIVE ESTROGEN RECEPTOR IN PREMALIGNANT BREAST$250,646
R01 · FY2000 · CA
MOLECULAR VARIANTS &OVEREXPRESSION OF ESTROGEN RECEPTORS IN BREAST CANCER$181,487
P01 · FY2000 · CA
HEAT SHOCK PROTEINS AND DRUG RESISTANCE$0
P50 · FY2000 · CA
HEAT SHOCK PROTEINS AND DRUG RESISTANCE$0
P50 · FY2000 · CA